| | MIR138-2, MIR140 +1738 more | Copy number gain | See cases | |
| | LOC130059829, LOC130059830 +1429 more | Copy number gain | See cases | |
| | LOC108281164, LOC109029536 +1426 more | Copy number gain | See cases | |
| | LOC130059834, LOC130059835 +1424 more | Copy number gain | See cases | |
| | LOC130059850, LOC130059851 +1041 more | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | LOC130059772, LOC130059773 +832 more | Copy number gain | See cases | |
| | LOC132090418, LOC132090419 +788 more | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | LOC130059746, LOC130059747 +719 more | Copy number gain | See cases | |
| | LOC130059500, LOC130059501 +691 more | Copy number gain | See cases | |
| | LOC132090448, LOC132090449 +677 more | Copy number gain | See cases | |
| | LOC130059591, LOC130059592 +670 more | Copy number gain | See cases | |
| | LOC130059691, LOC130059692 +566 more | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number loss | See cases | |
| | LOC130059838, LOC130059839 +18 more | Deletion | Fanconi anemia | |
| | FANCA, LOC112486223 +30 more | Copy number loss | See cases | |
| | | Copy number loss | See cases | |
| | | Deletion | not provided | |
| | | Single nucleotide variant | not provided | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | not provided +1 more | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 +1 more | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | not provided | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | not provided +1 more | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | not provided +1 more | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 +1 more | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 +1 more | |
| | | Single nucleotide variant (genic downstream transcript variant) | not provided +1 more | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | not provided +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (5 prime UTR variant) | not provided +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Deletion (5 prime UTR variant) | Malignant Melanoma Susceptibility | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (5 prime UTR variant) | not provided +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | not provided +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Duplication (5 prime UTR variant) | Malignant Melanoma Susceptibility | |
| | | Deletion (inframe_deletion +1 more) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 +1 more | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (nonsense) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Microsatellite (inframe_deletion) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Deletion (frameshift variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (synonymous variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |